T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor

Allogeneic hematopoietic cell transplantation (allo-HCT) is an essential therapeutic modality for patients with hematological malignancies and other blood disorders. Unfortunately, acute graft-versus-host disease (aGVHD) remains a major source of morbidity and mortality following allo-HCT, which lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Hua, Fu, Denggang, Bidgoli, Alan, Paczesny, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525316/
https://www.ncbi.nlm.nih.gov/pubmed/34675938
http://dx.doi.org/10.3389/fimmu.2021.761448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525316/
https://www.ncbi.nlm.nih.gov/pubmed/34675938
http://dx.doi.org/10.3389/fimmu.2021.761448

Ejemplares similares